Robert G Penn, MD in Omaha, NE - Medicare Infectious Disease

Robert G Penn, MD is a medicare enrolled "Internal Medicine - Infectious Disease" physician in Omaha, Nebraska. He went to University Of Nebraska College Of Medicine and graduated in 1975 and has 49 years of diverse experience with area of expertise as Infectious Disease. He is a member of the group practice Infectious Diseases Associates Pc and his current practice location is 8111 Dodge St, Suite 363, Omaha, Nebraska. You can reach out to his office (for appointments etc.) via phone at (402) 354-8155.

Robert G Penn is licensed to practice in Nebraska (license number 13129) and he also participates in the medicare program. He accepts medicare assignments (which means he accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and his NPI Number is 1013937374.

Contact Information

	Robert G Penn, MD
	8111 Dodge St, Suite 363, Omaha, NE 68114-4129
	(402) 354-8155
	(402) 354-8159

Physician's Profile

Full Name	Robert G Penn
Gender	Male
Speciality	Infectious Disease
Experience	49 Years
Location	8111 Dodge St, Omaha, Nebraska
Accepts Medicare Assignments	Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.

Medical Education and Training:

Robert G Penn attended and graduated from University Of Nebraska College Of Medicine in 1975

NPI Data:

NPI Number: 1013937374
Provider Enumeration Date: 07/20/2006
Last Update Date: 12/13/2013

Medicare PECOS Information:

PECOS PAC ID: 0547168312
Enrollment ID: I20100109000010

Medical Identifiers

Medical identifiers for Robert G Penn such as npi, medicare ID, medicare PIN, medicaid, etc.

Identifier	Type	State	Issuer
1013937374	NPI	-	NPPES
0923557	Medicaid	IA
202111902	Medicaid	MO
01565	Other	NE	BCBS

Medical Taxonomies and Licenses

Taxonomy	Type	License (State)	Status
207RI0200X	Internal Medicine - Infectious Disease	13129 (Nebraska)	Primary

Medical Facilities Affiliation

Facility Name	Location	Facility Type
The Nebraska Methodist Hospital	Omaha, NE	Hospital

Group Practice Association

Group Practice Name	Group PECOS PAC ID	No. of Members
Infectious Diseases Associates Pc	5597663369	4

News Archive

Urologix 2010 fourth quarter net loss decreases 28.9% to $0.04 per share

Urologix, a medical device company that develops, manufactures and markets minimally invasive Cooled ThermoTherapy™ technology to urologists to provide a durable and effective in-office treatment for patients suffering from benign prostatic hyperplasia (BPH), today reported financial results for its fourth quarter ended June 30, 2010 and for fiscal year 2010.

Zirconia-doped ceria nanoparticles can act as effective antioxidants in sepsis treatment

During sepsis, cells are swamped with reactive oxygen species generated in an aberrant response of the immune system to a local infection.

Navigating Cancer receives ONC-ATCB certification for Patient Engagement Portal

Navigating Cancer's Patient Engagement Portal, the industries only oncology specific solution that can integrate with any electronic health record (EHR) system, has received the federal government's "meaningful use" stamp of approval by earning (EHR) modular certification.

Human Genome Sciences has begun dosing patients with chronic hep C drug

Human Genome Sciences, Inc. announced today that it has begun dosing patients in a Phase 2 clinical trial of Albuferon™ (albumin-interferon alpha) in patients with chronic hepatitis C who are naïve to interferon-alpha treatments.

Watson Pharmaceuticals receives FDA approval for mint coated nicotine gum

Watson Pharmaceuticals, Inc. has received approval from the United States Food and Drug Administration to market its over-the-counter Nicotine Polacrilex Gum USP, coated mint flavor, in the 2 mg and 4 mg strengths.

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Robert G Penn allows following entities to bill medicare on his behalf.

Entity Name	Infectious Diseases Associates Pc
Entity Type	Part B Supplier - Clinic/group Practice
Entity Identifiers	NPI Number: 1164448510 PECOS PAC ID: 5597663369 Enrollment ID: O20031230000788

News Archive

Urologix 2010 fourth quarter net loss decreases 28.9% to $0.04 per share

Zirconia-doped ceria nanoparticles can act as effective antioxidants in sepsis treatment

During sepsis, cells are swamped with reactive oxygen species generated in an aberrant response of the immune system to a local infection.

Navigating Cancer receives ONC-ATCB certification for Patient Engagement Portal

Human Genome Sciences has begun dosing patients with chronic hep C drug

Watson Pharmaceuticals receives FDA approval for mint coated nicotine gum

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Robert G Penn is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing Address	Practice Location Address
Robert G Penn, MD 8111 Dodge St, Suite 363, Omaha, NE 68114-4129 Ph: (402) 354-8155	Robert G Penn, MD 8111 Dodge St, Suite 363, Omaha, NE 68114-4129 Ph: (402) 354-8155

News Archive

Urologix 2010 fourth quarter net loss decreases 28.9% to $0.04 per share

Zirconia-doped ceria nanoparticles can act as effective antioxidants in sepsis treatment

During sepsis, cells are swamped with reactive oxygen species generated in an aberrant response of the immune system to a local infection.

Navigating Cancer receives ONC-ATCB certification for Patient Engagement Portal

Human Genome Sciences has begun dosing patients with chronic hep C drug

Watson Pharmaceuticals receives FDA approval for mint coated nicotine gum

Internal Medicine Doctors in Omaha, NE

Dr. Marium Ilahi, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 7710 Mercy Rd, Suite 426, Omaha, NE 68124 Phone: 402-717-3636 Fax: 402-717-5050
Dr. Vidhya Murukesan, M.B.,B.S Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 601 N 30th St, Creighton University - Gme, Omaha, NE 68131 Phone: 402-280-5250
Matthew John Kapalis, DO Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 7500 Mercy Rd, Omaha, NE 68124 Phone: 402-398-6255 Fax: 402-398-6255
Abbie K Ray-deering, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 17500 Burke St, Omaha, NE 68118 Phone: 402-354-2360 Fax: 402-354-2440
Dr. Elizabeth Rini Schnaubelt, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: Emile @ 42nd St, Omaha, NE 68198 Phone: 402-559-4015 Fax: 402-559-5581
Sarah Kesterson, M.D. Infectious Disease Medicare: Medicare Enrolled Practice Location: 982055 Nebraska Medical Ctr, Omaha, NE 68198 Phone: 402-559-7792 Fax: 402-559-9385
Dr. Lauren C Licitra, M.D. Infectious Disease Medicare: Medicare Enrolled Practice Location: 42 Nd And Emile St, Omaha, NE 68198 Phone: 402-559-4000

Robert G Penn, MD - Medicare Infectious Disease in Omaha, NE

Contact Information

Physician's Profile

Medical Identifiers

Medical Taxonomies and Licenses

Medical Facilities Affiliation

Group Practice Association

Urologix 2010 fourth quarter net loss decreases 28.9% to $0.04 per share

Zirconia-doped ceria nanoparticles can act as effective antioxidants in sepsis treatment

Navigating Cancer receives ONC-ATCB certification for Patient Engagement Portal

Human Genome Sciences has begun dosing patients with chronic hep C drug

Watson Pharmaceuticals receives FDA approval for mint coated nicotine gum

Medicare Reassignments

Urologix 2010 fourth quarter net loss decreases 28.9% to $0.04 per share

Zirconia-doped ceria nanoparticles can act as effective antioxidants in sepsis treatment

Navigating Cancer receives ONC-ATCB certification for Patient Engagement Portal

Human Genome Sciences has begun dosing patients with chronic hep C drug

Watson Pharmaceuticals receives FDA approval for mint coated nicotine gum

Medicare Part D Prescriber Enrollment

Mailing Address and Practice Location

Urologix 2010 fourth quarter net loss decreases 28.9% to $0.04 per share

Zirconia-doped ceria nanoparticles can act as effective antioxidants in sepsis treatment

Navigating Cancer receives ONC-ATCB certification for Patient Engagement Portal

Human Genome Sciences has begun dosing patients with chronic hep C drug

Watson Pharmaceuticals receives FDA approval for mint coated nicotine gum

Internal Medicine Doctors in Omaha, NE